Cloperastine fendizoate
Cloperastine fendizoate (Hustazol) is a potent, concentration-dependent inhibitor of the hERG potassium channel, with an IC50 of 27 nM. This property makes it a valuable pharmacological tool for in vitro cardiac safety research and studies of long QT syndrome mechanisms.
Product Specifications
CAS Number
85187-37-7
Product Name Alternative
Cloperastine fendizoate, hERG Potassium Channel, Hustazol, K+ currents
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.85% (May vary between batches)
Solubility
DMSO:8 mg/mL (12.34 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.54 mM)
Smiles
Clc1ccc (cc1) C (OCCN1CCCCC1) c1ccccc1.OC (=O) c1ccccc1C (=O) c1ccc (O) c (c1) -c1ccccc1
Molecular Formula
C40H38ClNO5
Molecular Weight
648.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog